In many quarters, there will be a warm welcome to this week’s announcement by Health Minister Mike Nesbitt to set up a ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

A daily pill could give patients the weight-loss benefits of gastric bypass surgery or drugs like Ozempic — with none of the ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...

Zaina Jasser urges patients and medical practitioners to be cautious of the moral and sociological implications of ...

after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...

The first head-to-head trial of Mounjaro and Wegovy, the weight-loss drugs, compared the effectiveness of the two leading ...

The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more effective than rival Wegovy.

Sophia Umansky, daughter of reality TV stars Kyle Richards and Mauricio Umansky, has addressed backlash over her decision to use the weight loss drug Mounjaro. The 25-year-old spoke to People ...